Bright Green (BGXX) Revenue & Revenue Breakdown
Bright Green Revenue Highlights
Latest Revenue (Y)
$401.49K
Bright Green Revenue by Period
Bright Green Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $401.49K | 97.24% |
| 2022-12-31 | $203.55K | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Bright Green generated $401.49K in revenue during NA 2023, up 97.24% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Bright Green Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $92.88K | -1726.28% |
| 2023-12-31 | $-5.71K | -103.45% |
| 2023-09-30 | $165.31K | 39.67% |
| 2023-06-30 | $118.36K | -4.19% |
| 2023-03-31 | $123.53K | 80.76% |
| 2022-12-31 | $68.34K | 45.90% |
| 2022-09-30 | $46.84K | -46.99% |
| 2022-06-30 | $88.37K | 698.64% |
| 2022-03-31 | $11.06K | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Bright Green generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Bright Green Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.42M |
| SNDL | SNDL | $909.01M | $197.75M |
| ORGO | Organogenesis | $433.14M | $115.18M |
| CGC | Canopy Growth | $297.15M | $73.96M |
| ACB | Aurora Cannabis | $233.29M | $64.42M |
| OGI | OrganiGram | $149.21M | $37.63M |
| CRON | Cronos Group | $120.27M | $38.68M |
| ALIM | Alimera Sciences | $80.75M | $23.01M |
| SXTC | China SXT Pharmaceuticals | $1.97M | $939.58K |
| BGXX | Bright Green | $401.49K | - |
| LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
| SHPH | Shuttle Pharmaceuticals | - | - |